Chronotherapy in hypertension: the devil is in the details
- 21 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (16), 1606-1607
- https://doi.org/10.1093/eurheartj/ehaa265
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy TrialEuropean Heart Journal, 2019
- Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia ProjectChronobiology International, 2016
- Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) studyBMJ Open, 2016
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudyThe Lancet, 2000
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997